From: STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
STK25 (high vs. low) | 1.11 (1.06, 1.16) |  < 0.001 | 1.10 (1.05, 1.15) |  < 0.001 |
Age (> 65 vs. ≦65) | 1.01 (0.99, 1.03) | 0.181 | – | – |
Gender (female vs. male) | 0.82 (0.56, 1.21) | 0.328 | – | – |
Child–Pugh grade (B–C vs. A) | 1.63 (0.73, 3.65) | 0.234 | – | – |
TNM stage(II vs. I) | 1.06 (0.52, 2.19) | 0.868 | 0.82 (0.37, 1.83) | 0.632 |
(III vs. I) | 1.96 (0.99, 3.88) | 0.053 | 1.92 (0.91, 4.04) | 0.087 |
(IV vs. I) | 6.27 (1.86, 21.14) | 0.003 | 10.39 (2.85, 37.95) |  < 0.001 |
Histologic grade (G3–G4 vs. G1–G2) | 1.29 (0.734, 2.26) | 0.374 | – | – |
Invasion(Yes vs. No) | 1.67 (0.93, 2.98) | 0.083 | 2.00 (1.04, 3.86) | 0.038 |
Ishak score (5–6 vs. 0–4) | 1.03 (0.58, 1.83) | 0.932 | – | – |